Orange Book product · Brand (NDA)
IYUZEH
LATANOPROST
At a glance
Dec 13, 2022
Approved
Brand (NDA)
Application
Not listed
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 13, 2022
3 yr 7 mo ago
Today
Patent 8637054 expires
Listed drug product patent expiration.
Jul 08, 2031
in 5 yr 2 mo
Pharmaceutical detail
Active ingredient
LATANOPROST
Strength
0.005%
Dosage form
SOLUTION/DROPS
Route
OPHTHALMIC
TE code
Not listed
Application
NDA 216472
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2018XELPROSBrand (NDA)
NDA 206185 · SUN PHARM
- 1996XALATANBrand (NDA)
NDA 020597 · UPJOHN
- 2025LATANOPROSTGeneric (ANDA)
ANDA 220360 · MANKIND PHARMA
- 2025LATANOPROSTGeneric (ANDA)
ANDA 219306 · MICRO LABS
- 2024LATANOPROSTGeneric (ANDA)
ANDA 218257 · GLAND
- 2019LATANOPROSTGeneric (ANDA)
ANDA 206519 · EUGIA PHARMA
- 2016LATANOPROSTGeneric (ANDA)
ANDA 202442 · FDC LTD
- 2013LATANOPROSTGeneric (ANDA)
ANDA 202077 · CARNEGIE
- 2011LATANOPROSTGeneric (ANDA)
ANDA 090887 · EPIC PHARMA LLC
- 2011LATANOPROSTGeneric (ANDA)
ANDA 200925 · AMRING PHARMS
- 2011LATANOPROSTGeneric (ANDA)
ANDA 077697 · APOTEX INC
- 2011LATANOPROSTGeneric (ANDA)
ANDA 201006 · BAUSCH AND LOMB
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8637054 | Jul 08, 2031 | in 5 yr 2 mo | ProductU-446 |

